IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
Titel:
IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
Auteur:
van den Berg, Victor J. Haskard, Dorian O. Fedorowski, Artur Hartley, Adam Kardys, Isabella Caga-Anan, Mikhail Akkerhuis, K. Martijn Oemrawsingh, Rohit M. van Geuns, Robert Jan de Jaegere, Peter van Mieghem, Nicolas Regar, Evelyn Ligthart, Jurgen M.R. Umans, Victor A.W.M. Serruys, Patrick W. Melander, Olle Boersma, Eric Khamis, Ramzi Y.